|
Nov 15
|
Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors
|
|
Nov 8
|
ADC Therapeutics SA (NYSE:ADCT) Q3 2023 Earnings Call Transcript
|
|
Nov 8
|
Q3 2023 ADC Therapeutics SA Earnings Call
|
|
Nov 7
|
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates
|
|
Nov 7
|
ADC Therapeutics Receives NYSE Notice of Non-Compliance With Continued Listing Standards
|
|
Nov 7
|
ADC Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
|
|
Nov 6
|
ADC Therapeutics to Participate in the Jefferies London Healthcare Conference
|
|
Nov 2
|
Puma Biotech (PBYI) Tops Q3 Earnings Estimates
|
|
Nov 2
|
ADC Therapeutics Announces Abstracts Accepted for Presentation at the 65th ASH Annual Meeting
|
|
Nov 1
|
Ligand Pharmaceuticals (LGND) Earnings Expected to Grow: Should You Buy?
|
|
Oct 31
|
ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Aug 10
|
Novo Nordisk (NVO) Q2 Earnings and Sales Miss, 2023 View Up
|
|
Aug 9
|
Horizon (HZNP) Q2 Earnings Top, Krystexxa & Uplizna Boost Sales
|
|
Aug 9
|
Q2 2023 ADC Therapeutics SA Earnings Call
|
|
Aug 8
|
Zoetis' (ZTS) Q2 Earnings and Revenues Surpass Estimates
|
|
Aug 8
|
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
|
|
Aug 8
|
ADC Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
|
|
Aug 7
|
MannKind (MNKD) Reports Break-Even Earnings for Q2
|
|
Aug 4
|
Intra-Cellular (ITCI) Q2 Earnings & Sales Top, '23 View Raised
|
|
Aug 4
|
Ultragenyx (RARE) Q2 Loss Wider Than Expected, Revenues Beat
|